Patients Say GSK Lyme Disease Vaccine Caused Arthritis

Law360, New York (August 8, 2012, 3:43 PM EDT) -- In a pair of suits removed to Pennsylvania federal court by GlaxoSmithKline LLC on Tuesday, two plaintiffs allege the pharmaceutical company's Lyme disease vaccine LYMERix caused treatment-resistant Lyme arthritis.

According to the complaint, the plaintiffs, who were inoculated with LYMERix in the late 1990s, were later diagnosed with post-Lyme disease treatment syndrome or treatment-resistant Lyme arthritis. The complaint said that patients with a certain genetic blood trait are more likely to develop the condition. The suits allege that GSK, which first began selling LYMERix in 1998,...
To view the full article, register now.